Online prediction tools for melanoma survival: A comparison

Author:

Dixon A.1ORCID,Steinman H. K.2ORCID,Kyrgidis A.3ORCID,Smith H.4,Sladden M.5,Zouboulis C.6ORCID,Argenziano G.7ORCID,Apalla Z.3ORCID,Lallas A.3ORCID,Longo C.89ORCID,Nirenberg A.1,Popescu C.10ORCID,Tzellos T.11ORCID,Cleaver L.12,Zachary C.13ORCID,Anderson S.1,Thomas J. M.14

Affiliation:

1. Australasian College of Cutaneous Oncology Victoria Melbourne Australia

2. Campbell University Buies Creek North Carolina USA

3. Aristotle University of Thessaloniki Thessaloniki Greece

4. Oxford Dermatology Western Australia Perth Australia

5. University of Tasmania Tasmania Launceston Australia

6. Staedtisches Klinikum Dessau, Brandenburg Medical School Dessau Germany

7. Dermatology University of Campania Naples Italy

8. University of Modena and Reggio Emilia Modena Italy

9. Azienda Unita Sanitaria Locale IRCCS di Reggio Emilia, Skin Cancer Center Regio Emilia Italy

10. Carol Davila University of Medicine and Pharmacy Bucharest Romania

11. Arctic University of Norway Tromsø Norway

12. AT Still University Missouri Kirksville USA

13. University of California Irvine California Irvine USA

14. Formerly of Royal Marsden Hospital, Chelsea London UK

Abstract

AbstractBackgroundBreslow thickness, patient age and ulceration are the three most valuable clinical and pathological predictors of melanoma survival. A readily available reliable online tool that accurately considers these and other predictors could be valuable for clinicians managing melanoma patients.ObjectiveTo compare online melanoma survival prediction tools that request user input on clinical and pathological features.MethodsSearch engines were used to identify available predictive nomograms. For each, clinical and pathological predictors were compared.ResultsThree tools were identified. The American Joint Committee on Cancer tool inappropriately rated thin tumours as higher risk than intermediate tumours. The University of Louisville tool was found to have six shortcomings: a requirement for sentinel node biopsy, unavailable input of thin melanoma or patients over 70 years of age and less reliable hazard ratio calculations for age, ulceration and tumour thickness. The LifeMath.net tool was found to appropriately consider tumour thickness, ulceration, age, sex, site and tumour subtype in predicting survival.LimitationsThe authors did not have access to the base data used to compile various prediction tools.ConclusionThe LifeMath.net prediction tool is the most reliable for clinicians in counselling patients with newly diagnosed primary cutaneous melanoma regarding their survival prospects.

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. BAUSSS biomarker improves melanoma survival risk assessment;Journal of the European Academy of Dermatology and Venereology;2024-08-31

2. Age matters: Rethinking SLNB's reliability in melanoma mortality prediction;Journal of the European Academy of Dermatology and Venereology;2024-03-25

3. Primary Cutaneous Melanoma—Management in 2024;Journal of Clinical Medicine;2024-03-11

4. BAUSSS biomarker further validated as a key risk staging tool for patients with primary melanoma;Journal of the European Academy of Dermatology and Venereology;2024-02-20

5. Sentinel lymph node biopsy is unreliable in predicting melanoma mortality for both younger and older patients;Journal of the European Academy of Dermatology and Venereology;2024-01-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3